NextCure, Inc.
NXTC
$0.3612
$0.02647.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 11.27% | 10.74% | 12.67% | 9.25% | 16.07% |
| Total Depreciation and Amortization | -22.23% | -22.03% | -17.28% | -12.72% | -10.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.91% | -16.31% | -20.92% | -22.51% | -38.41% |
| Change in Net Operating Assets | 333.61% | 206.40% | 76.84% | -70.34% | -152.08% |
| Cash from Operations | 22.97% | 13.16% | 14.30% | 4.54% | 1.69% |
| Capital Expenditure | 42.20% | 68.84% | 67.27% | 70.42% | 61.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.13% | 28.56% | -8.15% | -46.76% | -42.80% |
| Cash from Investing | 40.83% | 32.67% | -5.74% | -46.09% | -42.23% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -6.49% | 24.31% | 23.61% | 10.71% | -23.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -6.49% | 24.31% | 23.61% | 10.71% | -23.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 208.10% | 170.97% | 80.94% | -160.12% | -194.79% |